Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinomaopen access
- Authors
- Lee, Hong Kyu; Kwon, Mi Jung; Ra, Yong Joon; Lee, Hee Sung; Kim, Hyoung Soo; Nam, Eun Sook; Cho, Seong Jin; Park, Hye-Rim; Min, Soo Kee; Seo, Jinwon; Choe, Ji-Young; Min, Kyueng-Whan; Kang, So Young
- Issue Date
- Oct-2020
- Publisher
- BMC
- Keywords
- Programmed death-ligand 1; Esophagus; Squamous cell carcinoma; Microsatellite instability; Human papillomavirus; PIK3CA
- Citation
- DIAGNOSTIC PATHOLOGY, v.15, no.1, pp.1 - 12
- Indexed
- SCIE
SCOPUS
- Journal Title
- DIAGNOSTIC PATHOLOGY
- Volume
- 15
- Number
- 1
- Start Page
- 1
- End Page
- 12
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/145028
- DOI
- 10.1186/s13000-020-01045-4
- ISSN
- 1746-1596
- Abstract
- Background: Esophageal squamous cell carcinoma (ESCC) still remains intractable disease with few therapeutic options. Programmed death-ligand 1 (PD-L1), which is essential for immune evasion, is involved in the pathogenesis of ESCC and thus is a potential therapeutic target.PIK3CA,KRAS, andBRAFmutations, microsatellite instability (MSI) caused by deficient mismatch repair (dMMR), and human papillomavirus (HPV) can potentially upregulate PD-L1 expression, which might contribute to the clinical outcome of patients with ESCC.
Methods: We investigated the significance of the present druggable markers [PD-L1,PIK3CA,KRAS, andBRAFmutations, MSI caused by deficient dMMR, and HPV] in 64 curatively resected ESCCs, using immunohistochemistry (PD-L1 and MMR protein expression), direct sequencing (KRAS,BRAF, andPIK3CAmutations), real-time PCR (HPV infection), and MSI using quasi-monomorphic markers.
Results: PD-L1 expression,PIK3CAmutation, and MSI/dMMR were detected in 35.9, 12.5, and 17.2% of ESCCs, respectively. HPV was rarely detected (1.6%) (high-risk HPV68), whereasKRASandBRAFmutations were not detected in ESCCs. PD-L1-positive tumors were not correlated withPIK3CAmutation or MSI/dMMR (allP > 0.05). PD-L1,PIK3CAmutation, and MSI/dMMR characterized the patients associated with light smoking, female and younger age, and younger age and well-differentiated tumors, respectively (allP < 0.05). In multivariate analysis, only PD-L1-positivity was an independent favorable prognostic factor for overall survival (OS) and disease-free survival (DFS) (P = 0.023,P = 0.014). In the PD-L1-negative ESCCs,PIK3CAmutation had a poor prognostic impact on both OS and DFS (P = 0.006,P = 0.002).
Conclusions: PIK3CAmutation may be an alternative prognostic biomarker in PD-L1-negative curatively resected ESCCs that can be optional to identify high-risk patients with worse clinical outcome who require more intensive therapy and follow-up.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 병리학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/145028)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.